摘要
目的观察利培酮合用西酞普兰治疗强迫症的疗效和不良反应。方法将40例强迫症患者随机分为两组,分别给予利培酮合用西酞普兰及单用西酞普兰治疗,疗程8周;以强迫症量表(Y-BOCS)和汉密尔顿焦虑量表(HAMA)评定疗效,以副反应量表(TESS)评定副反应。结果利培酮合用西酞普兰组显效率高于单用组,8周末Y-BOCS评分低于单用组。结论利培酮合用西酞普兰治疗强迫症安全有效。
Objective To observe the effect and harmful reaction of risperidone puls citalopram therapy in treatment of obsessive compulsive disorder. Methods The obsessive compulsive disorder patients were assigned to two groups and given risperidone plus citalopram and eitalopram respectively. The course of treatment was eight weeks. To evaluate the effect with Y-BOCS and HAMA and evaluate the harmful reation with TESS. Results The therapeutie efficacy in group of risperidone plus eitalopram was significantly higher than that in group of eitalopram only. And the evaluation marks was lower than that in group of eitalopram only. Conclusion Risperidone plus eitalopram therapy in treatment of obsessive compulsive disorder was safe and effective.
出处
《中国健康心理学杂志》
2009年第5期638-639,共2页
China Journal of Health Psychology
关键词
利培酮
西酞普兰
强迫症
副反应量表
Risperidone
Citalopram
Obsessive compulsive disorder
TESS
